Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 6
2018 6
2019 9
2020 9
2021 13
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

46 results
Results by year
Filters applied: . Clear all
Page 1
Erratum for Sekaggya-Wiltshire et al., "Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?".
Sekaggya-Wiltshire C, Chirehwa M, Musaazi J, von Braun A, Buzibye A, Muller D, Gutteck U, Motta I, Calcagno A, Fehr JS, Kambugu A, Castelnuovo B, Lamorde M, Denti P. Sekaggya-Wiltshire C, et al. Antimicrob Agents Chemother. 2020 Mar 24;64(4):e00315-20. doi: 10.1128/AAC.00315-20. Print 2020 Mar 24. Antimicrob Agents Chemother. 2020. PMID: 32209563 Free PMC article. No abstract available.
Safety and efficacy of hydroxychloroquine for treatment of non-severe COVID-19 among adults in Uganda: a randomized open label phase II clinical trial.
Byakika-Kibwika P, Sekaggya-Wiltshire C, Semakula JR, Nakibuuka J, Musaazi J, Kayima J, Sendagire C, Meya D, Kirenga B, Nanzigu S, Kwizera A, Nakwagala F, Kisuule I, Wayengera M, Mwebesa HG, Kamya MR, Bazeyo W. Byakika-Kibwika P, et al. Among authors: sekaggya wiltshire c. BMC Infect Dis. 2021 Dec 6;21(1):1218. doi: 10.1186/s12879-021-06897-9. BMC Infect Dis. 2021. PMID: 34872511 Free PMC article. Clinical Trial.
Optimal therapy for multidrug-resistant tuberculosis and HIV.
Mayanja-Kizza H, Sekaggya-Wiltshire C, Kassa D. Mayanja-Kizza H, et al. Among authors: sekaggya wiltshire c. Lancet. 2020 Aug 8;396(10248):363-365. doi: 10.1016/S0140-6736(20)31688-3. Lancet. 2020. PMID: 32771093 No abstract available.
One dollar incentive improves tuberculosis treatment outcomes in programmatic settings in rural Uganda.
Baluku JB, Nakazibwe B, Twinomugisha B, Najjuuko R, Isabella N, Nassozi S, Namiiro S, Katagira W, Byonanebye DM, Sekaggya-Wiltshire C, Muchiri J, Ndungu E, Anguzu G, Mayanja-Kizza H, Andia-Biraro I. Baluku JB, et al. Among authors: sekaggya wiltshire c. Sci Rep. 2021 Sep 29;11(1):19346. doi: 10.1038/s41598-021-98770-7. Sci Rep. 2021. PMID: 34588552 Free PMC article. Clinical Trial.
Developing and Validating a Clinical Warfarin Dose-Initiation Model for Black-African Patients in South Africa and Uganda.
Asiimwe IG, Waitt C, Sekaggya-Wiltshire C, Hutchinson C, Okello E, Zhang EJ, Semakula JR, Mouton JP, Cohen K, Blockman M, Lamorde M, Jorgensen AL, Pirmohamed M. Asiimwe IG, et al. Among authors: sekaggya wiltshire c. Clin Pharmacol Ther. 2021 Jun;109(6):1564-1574. doi: 10.1002/cpt.2128. Epub 2020 Dec 28. Clin Pharmacol Ther. 2021. PMID: 33280090
46 results